Industries

Pharma

Solutions designed for growth

As your partner, Alira Health can help you navigate today’s evolving pharmaceutical industry. With an increased focus on personalized care, the current pharma landscape has a wider range of clusters, each with smaller patient pools. Your dedicated Alira Health team will work closely with you to identify the short- and long-term impacts to your goals, and create tailored solutions.
  • Research and development expenditures
  • Supply chain capacities
  • Pricing strategies

Why choose Alira Health?

As your partner, we’ll work closely with you to uncover opportunities across the pharma industry, accelerate innovation, and deliver tomorrow’s standard of care. You’ll benefit from our:

  • 360° lifecycle approach

    that supports products, technologies, and services from concept ideation to creation and commercialization

  • Regulatory

    clinical, and health expertise in medical affairs strategy and execution

  • Management consulting

    to define growth initiatives and accelerate market penetration. Learn more

  • Global transaction advisory services

    including M&A, licensing, partnering and distribution, and capital raises. Learn more

  • In-depth experience

    across the entire healthcare ecosystem—suppliers, payers, providers, and patients

  • Fully collaborative team

    of bankers, scientists, strategists, and doctors who deliver a holistic view of each project

Areas of expertise

Alira Health teams bring together top talent from every life science and healthcare sector to take your innovation from strategy to reality. Our teams specialize in:
  • Central nervous system
  • Metabolic diseases
  • Oncology
  • Rare and orphan diseases
  • Infectious diseases
  • Dermatology
  • Genetic diseases
  • Addiction diseases
  • Hematology

Local insights, global reach

Since 1999, Alira Health has increased value for its pharma, biotech, and MedTech clients around the world. Our local presence and global collaboration combined with our deep domain experience allows us to deliver actionable insights.
20+
Years serving pharma and MedTech clients
75%
Of the top 50 pharma companies are advised by Alira Health

Working together to humanize healthcare

As your industry evolves, we’re ready to help you lead the way.

Contact us
Gabriele Brambilla
Gabriele Brambilla
Chief Executive Officer
Our clients are disrupting healthcare—they are pioneering new standards of care, and we are their accelerator.

Explore our related publications:

Publications June 23, 2022
Developing Data Specialist Talent: Collaboration Is Key
Companies across Pharma and MedTech need talented people to cover the range of data-related challenges. Discover what this means for developing talent throughout the industry.
Data Specialist MedTech Pharma
News May 11, 2022
Alira Health Acquires RedCrow, an Equity Crowdfunding Platform for Healthcare Startups
We acquired RedCrow, an alternative investment platform that provides individual investors with easy access to expert-vetted healthcare start-ups. The financial terms of the transaction(...)
MedTech Patient Engagement Pharma
News April 5, 2022
Alira Health Strengthens Clinical Operations with the Acquisition of Sourcia
We acquired a full-service Contract Research Organization (CRO), Sourcia, that provides services for Phase I to Phase IV clinical trials with a focus on biotech, medical devices, and(...)
Clinical MedTech Patient Engagement Pharma Regulatory Research & Development
Publications March 31, 2022
The FDA’s Project Orbis Can Speed up the Delivery of Your New Oncology Drug to Global Markets
Are you developing an oncology drug? Project Orbis, a program coordinated by the U.S. Food and Drug Administration (FDA), allows you to register your product in several countries with(...)
Pharma Regulatory
Events March 4, 2022
Bio Europe Spring 2022
Meet us at Bio Europe Spring 2022. Connect with us to learn how Alira Health can help accelerate innovation and deliver tomorrow’s standard of care.
Pharma
Events February 14, 2022
Conferenza Nazionale Sulla Farmaceutica
We are thrilled to sponsor and attend Conferenza Nazionale Sulla Farmaceutica 2022 in Catania, Italy 
Pharma
News January 13, 2022
Alira Health Secures an Additional $40M in Funding, Led by Creadev
We announced today the closing of an equity financing in which it raised gross proceeds of US$40 million. We intend to use the funds to invest in solutions that actively engage patients(...)
M&A MedTech Pharma
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.